Schulte Roth & Zabel represented Commodore Capital in the transaction.In connection with its acquisition of AlmataBio, Avalo Therapeutics, Inc. issued a PIPE consisting of preferred stock…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Laura Testa
…
This content is for Standard 1 Year members only. LoginJoin Now